[
    {
        "uuid": "32be4ac1-23d2-3049-85ac-29b0ec900447",
        "title": "CNS Pharmaceuticals Receives Approval from U.S. FDA for Protocol Amendment to Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM",
        "publisher": "PR Newswire",
        "link": "https://finance.yahoo.com/news/cns-pharmaceuticals-receives-approval-u-123500327.html",
        "providerPublishTime": 1655987700,
        "type": "STORY",
        "thumbnail": {
            "resolutions": [
                {
                    "url": "https://s.yimg.com/uu/api/res/1.2/NUM08wtuAB1ACzJpmPy8YQ--~B/aD0xOTU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/qZ93nvn4lSzaRIV13helXw--~B/aD0xOTU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/ee5e06bf58cf922551c7dbc615fddcde",
                    "width": 400,
                    "height": 195,
                    "tag": "original"
                },
                {
                    "url": "https://s.yimg.com/uu/api/res/1.2/NwuwqEbYYFs44QL65gkgjw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/qZ93nvn4lSzaRIV13helXw--~B/aD0xOTU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/ee5e06bf58cf922551c7dbc615fddcde",
                    "width": 140,
                    "height": 140,
                    "tag": "140x140"
                }
            ]
        },
        "relatedTickers": [
            "CNSP"
        ]
    },
    {
        "uuid": "80d565e2-ffa4-3b82-8712-50274c96c44f",
        "title": "CNS Pharmaceuticals Announces Presentation of Ongoing Potentially Pivotal Berubicin Clinical Trial Design at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting",
        "publisher": "PR Newswire",
        "link": "https://finance.yahoo.com/news/cns-pharmaceuticals-announces-presentation-ongoing-123500187.html",
        "providerPublishTime": 1654691700,
        "type": "STORY",
        "thumbnail": {
            "resolutions": [
                {
                    "url": "https://s.yimg.com/uu/api/res/1.2/NUM08wtuAB1ACzJpmPy8YQ--~B/aD0xOTU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/qZ93nvn4lSzaRIV13helXw--~B/aD0xOTU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/ee5e06bf58cf922551c7dbc615fddcde",
                    "width": 400,
                    "height": 195,
                    "tag": "original"
                },
                {
                    "url": "https://s.yimg.com/uu/api/res/1.2/NwuwqEbYYFs44QL65gkgjw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/qZ93nvn4lSzaRIV13helXw--~B/aD0xOTU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/ee5e06bf58cf922551c7dbc615fddcde",
                    "width": 140,
                    "height": 140,
                    "tag": "140x140"
                }
            ]
        },
        "relatedTickers": [
            "CNSP"
        ]
    },
    {
        "uuid": "4ff308b7-0a3c-3958-9b77-2736d75c1dc9",
        "title": "CNS Pharmaceuticals Announces Presentation at the H.C. Wainwright Global Investment Conference",
        "publisher": "PR Newswire",
        "link": "https://finance.yahoo.com/news/cns-pharmaceuticals-announces-presentation-h-110000687.html",
        "providerPublishTime": 1653390000,
        "type": "STORY",
        "thumbnail": {
            "resolutions": [
                {
                    "url": "https://s.yimg.com/uu/api/res/1.2/NUM08wtuAB1ACzJpmPy8YQ--~B/aD0xOTU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/qZ93nvn4lSzaRIV13helXw--~B/aD0xOTU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/ee5e06bf58cf922551c7dbc615fddcde",
                    "width": 400,
                    "height": 195,
                    "tag": "original"
                },
                {
                    "url": "https://s.yimg.com/uu/api/res/1.2/NwuwqEbYYFs44QL65gkgjw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/qZ93nvn4lSzaRIV13helXw--~B/aD0xOTU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/ee5e06bf58cf922551c7dbc615fddcde",
                    "width": 140,
                    "height": 140,
                    "tag": "140x140"
                }
            ]
        },
        "relatedTickers": [
            "CNSP"
        ]
    },
    {
        "uuid": "c32678b6-7e7a-3bb2-a908-23df8a05c0f7",
        "title": "CNS Pharmaceuticals to Present at American Society of Clinical Oncology Meeting",
        "publisher": "NewMediaWire",
        "link": "https://finance.yahoo.com/news/cns-pharmaceuticals-present-american-society-195700493.html",
        "providerPublishTime": 1652990220,
        "type": "STORY",
        "thumbnail": {
            "resolutions": [
                {
                    "url": "https://s.yimg.com/uu/api/res/1.2/iz_xFwW6ZKa36M34N0K7Tw--~B/aD0zNDt3PTIwMTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/tyHaUTOndDv0_pTWkEdCcw--~B/aD0zNDt3PTIwMTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/newsmediawire_165/07befad219f16ea8f5b5b1301026ccb7",
                    "width": 201,
                    "height": 34,
                    "tag": "original"
                },
                {
                    "url": "https://s.yimg.com/uu/api/res/1.2/Qe0qcG_hkvrwc_TfGHPH8A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/tyHaUTOndDv0_pTWkEdCcw--~B/aD0zNDt3PTIwMTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/newsmediawire_165/07befad219f16ea8f5b5b1301026ccb7",
                    "width": 140,
                    "height": 140,
                    "tag": "140x140"
                }
            ]
        },
        "relatedTickers": [
            "CNSP"
        ]
    },
    {
        "uuid": "31cc5597-0633-304c-82a8-80f7ac72d45a",
        "title": "CNS Pharmaceuticals Announces Acceptance of Abstract for Poster Presentation at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting",
        "publisher": "PR Newswire",
        "link": "https://finance.yahoo.com/news/cns-pharmaceuticals-announces-acceptance-abstract-123500592.html",
        "providerPublishTime": 1652877300,
        "type": "STORY",
        "thumbnail": {
            "resolutions": [
                {
                    "url": "https://s.yimg.com/uu/api/res/1.2/NUM08wtuAB1ACzJpmPy8YQ--~B/aD0xOTU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/qZ93nvn4lSzaRIV13helXw--~B/aD0xOTU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/ee5e06bf58cf922551c7dbc615fddcde",
                    "width": 400,
                    "height": 195,
                    "tag": "original"
                },
                {
                    "url": "https://s.yimg.com/uu/api/res/1.2/NwuwqEbYYFs44QL65gkgjw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/qZ93nvn4lSzaRIV13helXw--~B/aD0xOTU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/ee5e06bf58cf922551c7dbc615fddcde",
                    "width": 140,
                    "height": 140,
                    "tag": "140x140"
                }
            ]
        },
        "relatedTickers": [
            "CNSP"
        ]
    },
    {
        "uuid": "b409f685-1bf8-355a-9e34-a6f6213df91a",
        "title": "CNS Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update",
        "publisher": "PR Newswire",
        "link": "https://finance.yahoo.com/news/cns-pharmaceuticals-reports-first-quarter-120500265.html",
        "providerPublishTime": 1652702700,
        "type": "STORY",
        "thumbnail": {
            "resolutions": [
                {
                    "url": "https://s.yimg.com/uu/api/res/1.2/NUM08wtuAB1ACzJpmPy8YQ--~B/aD0xOTU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/qZ93nvn4lSzaRIV13helXw--~B/aD0xOTU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/ee5e06bf58cf922551c7dbc615fddcde",
                    "width": 400,
                    "height": 195,
                    "tag": "original"
                },
                {
                    "url": "https://s.yimg.com/uu/api/res/1.2/NwuwqEbYYFs44QL65gkgjw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/qZ93nvn4lSzaRIV13helXw--~B/aD0xOTU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/ee5e06bf58cf922551c7dbc615fddcde",
                    "width": 140,
                    "height": 140,
                    "tag": "140x140"
                }
            ]
        },
        "relatedTickers": [
            "CNSP"
        ]
    },
    {
        "uuid": "5949c0fc-c5a2-32c1-a779-911f6f1c411d",
        "title": "CNS Pharmaceuticals Receives Approval from Ethics Committee and Competent Authority in Spain for Potentially Pivotal Study of Berubicin for the Treatment of Glioblastoma Multiforme (GBM)",
        "publisher": "PR Newswire",
        "link": "https://finance.yahoo.com/news/cns-pharmaceuticals-receives-approval-ethics-123500657.html",
        "providerPublishTime": 1651149300,
        "type": "STORY",
        "thumbnail": {
            "resolutions": [
                {
                    "url": "https://s.yimg.com/uu/api/res/1.2/NUM08wtuAB1ACzJpmPy8YQ--~B/aD0xOTU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/qZ93nvn4lSzaRIV13helXw--~B/aD0xOTU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/ee5e06bf58cf922551c7dbc615fddcde",
                    "width": 400,
                    "height": 195,
                    "tag": "original"
                },
                {
                    "url": "https://s.yimg.com/uu/api/res/1.2/NwuwqEbYYFs44QL65gkgjw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/qZ93nvn4lSzaRIV13helXw--~B/aD0xOTU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/ee5e06bf58cf922551c7dbc615fddcde",
                    "width": 140,
                    "height": 140,
                    "tag": "140x140"
                }
            ]
        },
        "relatedTickers": [
            "CNSP"
        ]
    },
    {
        "uuid": "52a6af98-8b0c-30b6-8dbe-b8421ac02cce",
        "title": "JTC Team Announces Continuation of its Virtual Investor Spotlight Series with NASDAQ: AEZS, NASDAQ: CNSP, and NASDAQ: AREC",
        "publisher": "ACCESSWIRE",
        "link": "https://finance.yahoo.com/news/jtc-team-announces-continuation-virtual-144500713.html",
        "providerPublishTime": 1649861100,
        "type": "STORY",
        "relatedTickers": [
            "AEZS",
            "CNSP",
            "AREC"
        ]
    }
]